Immunity to malaria in an era of declining malaria transmission (Q38689264)

5 September 2017

Immunity to malaria in an era of declining malaria transmission (English)

1 reference

5 September 2017

0 references

Philippe Boeuf

2

0 references

James Beeson

series ordinal

3

object named as

James G Beeson

1 reference

5 September 2017

1

Freya J I Fowkes

1 reference

5 September 2017

7 January 2016

1 reference

5 September 2017

1 reference

5 September 2017

143

1 reference

5 September 2017

2

1 reference

5 September 2017

139-153

1 reference

Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection

5 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Memory T cells maintain protracted protection against malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Patterns in age-specific malaria incidence in a population exposed to low levels of malaria transmission intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Marked decline in malaria prevalence among pregnant women and their offspring from 1996 to 2010 on the south Kenyan Coast

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Trying to remember: immunological B cell memory to malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Spatial distribution of G6PD deficiency variants across malaria-endemic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

The global distribution of the Duffy blood group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Immunity to non-cerebral severe malaria is acquired after one or two infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Gradual acquisition of immunity to severe malaria with increasing exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Profiling the antibody immune response against blood stage malaria vaccine candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Severe imported malaria in adults: retrospective study of 20 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

A new world malaria map: Plasmodium falciparum endemicity in 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Frequent and persistent, asymptomatic plasmodium falciparum infections in african infants, characterized by multilocus genotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Dynamics of the antibody response to Plasmodium falciparum infection in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

The relationship of serum gamma-globulin concentration to malaria and sickling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Mechanisms of defense against P. falciparum asexual blood stages in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Acquired immunity to malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Correlates of protective immunity following whole sporozoite vaccination against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Local-scale variation in malaria infection amongst rural Gambian children estimated by satellite remote sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Dramatic declines in seropositivity as determined with crude extracts of Plasmodium falciparum schizonts between 2000 and 2010 in Dielmo and Ndiop, Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Decreasing malaria prevalence and its potential consequences for immunity in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Is immunity to malaria really short-lived?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Protection of Malian children from clinical malaria is associated with recognition of multiple antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Eleven years of malaria surveillance in a Sudanese village highlights unexpected variation in individual disease susceptibility and outbreak severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Does malaria suffer from lack of memory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Priming of CD4+ T cells and development of CD4+ T cell memory; lessons for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Using serological measures to monitor changes in malaria transmission in Vanuatu

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Studies on the persistence of malarial antibody response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Action of Malarial Antibody in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

The V gene repertoires of classical and atypical memory B cells in malaria-susceptible West African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Gamma-globulin and acquired immunity to human malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Antigenic variation in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Age- and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

[Clinical presentation and complications of Plasmodium falciparum malaria in two populations: travelers and immigrants].

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Cross-species interactions between malaria parasites in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Changing patterns of malaria during 1996-2010 in an area of moderate transmission in southern Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

The future for blood-stage vaccines against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Identification of hot spots of malaria transmission for targeted malaria control

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Pregnancy and malaria exposure are associated with changes in the B cell pool and in plasma eotaxin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Sexual-stage antibody responses to P. falciparum in endemic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Epidemiology of imported malaria give support to the hypothesis of 'long-term' semi-immunity to malaria in sub-Saharan African migrants living in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Recent insights into humoral and cellular immune responses against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand - molecular and serological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

The distribution of haemoglobin C and its prevalence in newborns in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

New antigens for a multicomponent blood-stage malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Malaria blood stage suppression of liver stage immunity by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Changes in the burden of malaria in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Identifying children with excess malaria episodes after adjusting for variation in exposure: identification from a longitudinal study using statistical count models

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Kinetics of B cell responses to plasmodium falciparum erythrocyte membrane protein 1 in ghanaian women naturally exposed to malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Metabolic properties of IgG subclasses in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Epidemiological features and case management practices of imported malaria in northern Italy 1991-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Imported malaria in adults and children: epidemiological and clinical characteristics of 380 consecutive cases observed in Verona, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

Prenatal immune priming in malaria: antigen-specific blastogenesis of cord blood lymphocytes from neonates born in a setting of holoendemic malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Antibody and B cell responses to Plasmodium sporozoites

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Clearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

A long neglected world malaria map: Plasmodium vivax endemicity in 2010

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Priming of CD8(+) T Cell Responses to Liver Stage Malaria Parasite Antigens

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Continued decline of malaria in The Gambia with implications for elimination

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Antibody to P. falciparum in pregnancy varies with intermittent preventive treatment regime and bed net use.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Research priorities for the development and implementation of serological tools for malaria surveillance

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Rapid assessment of malaria transmission using age-specific sero-conversion rates

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspots

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

The seroepidemiology of malaria in Middle America. I. Longitudinal studies on populations in a low incidence area of El Salvador

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

CD8 T-cell-mediated protection against liver-stage malaria: lessons from a mouse model

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

High number of previous Plasmodium falciparum clinical episodes increases risk of future episodes in a sub-group of individuals

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Cytokine and antibody responses to Plasmodium falciparum in naïve individuals during a first malaria episode: effect of age and malaria exposure

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Changes in B Cell Populations and Merozoite Surface Protein-1-Specific Memory B Cell Responses after Prolonged Absence of Detectable P. falciparum Infection

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Immune effector mechanisms in malaria

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Sero-epidemiological studies on population groups previously exposed to malaria

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

The risk of malarial infections and disease in Papua New Guinean children.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

A positive correlation between atypical memory B cells and Plasmodium falciparum transmission intensity in cross-sectional studies in Peru and Mali

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

Naturally acquired circumsporozoite antibodies and their role in protection in endemic falciparum and vivax malaria.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001249

7 January 2021

10.1017/S0031182015001249

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26741253